A University of California Irvine study reported 90% patient satisfaction in cancer patients who were offered a multilanguage electronic tool to report their symptoms.
The Latest
A clinical trial conducted by researchers at Rochester, Minn.-based Mayo Clinic and Minneapolis-based University of Minnesota found drug combinations eliminated or shrunk tumors in 70% of clinical trial participants with stage 3 melanoma.
The FDA has given fast-track designation to Diakonos Oncology for its pancreatic cancer vaccine.
Tampa (Fla.) General Hospital has received a "substantial" gift to develop a center of colorectal cancer excellence.
The median compensation for hematologists and medical oncologists increased 7.1% from 2023 to 2024, going from $498,062 to $533,402, according to the American Medical Group Association.
A University of Cambridge poll found 70% of people fear a late cancer diagnosis.
Cancer Resource Center of the Finger Lakes has affiliated with Ithaca, N.Y.-based Cayuga Health System, effective July 1.
Carilion Clinic in Roanoke, Va., received a $25 million gift to grow the health system's cancer program.
Among adults 30 and older, about 40% of cancer cases and nearly a half of all cancer deaths are linked to preventable risk factors, according to a new study from researchers at the American Cancer Society.
Findings from a recent study challenge a push to reclassify low grade prostate cancer, Biopsy Gleason Grade Group 1, as "benign."